Skip to content

Brain-based Prediction of the Dying Duration in Humans After Withdrawal of Life Sustaining Therapies to Inform Donation After Circulatory Death

Brain-based Prediction of the Dying Duration in Humans After Withdrawal of Life Sustaining Therapies to Inform Donation After Circulatory Death

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07698262
Acronym
NeuroDCD
Enrollment
102
Registered
2026-07-13
Start date
2027-01-01
Completion date
2030-12-01
Last updated
2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Organ Donation After Circulatory Death

Keywords

Predicting organ donation after circulatory death, DCD

Brief summary

The purpose of this study is to develop a new tool that uses information collected before life-sustaining treatments are withdrawn to better predict whether a patient will die within the time needed for organ donation to be possible. The tool created should help improve planning for organ donation and provide families and healthcare teams with more accurate information.

Interventions

None listed

Sponsors

University of British Columbia
Lead SponsorOTHER
Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 19; 2. Eligible for DCD

Exclusion criteria

1. Complete high cervical spinal cord injury (C5 and above) 2. Pacemaker in situ 3. Tracheostomy

Design outcomes

Primary

MeasureTime frameDescription
To develop a clinically applicable model to predict dying duration in a cohort of patient eligible for donation after circulatory deathThe models will be built to predict death within 30, 60 and 120 minutesSpecifically, we aim at assessing the predictive ability of blood-based brain biomarkers, optic nerve sheet diameter as measured by head computed tomography (CT) scans as a surrogate of intracranial pressure and autonomic dysfunction as reflected by abnormal heart rate variability (HRV) to predict the dying duration.

Secondary

MeasureTime frameDescription
Comparison of the brain-to-heart model to existing modelsThe models will be compared for death within 30, 60 and 120 minutesOur secondary aim will be to compare the created models with available models (e.g., DCD-N, UNOS, Wisconsin) and to physician gestalt

Countries

Canada

Contacts

CONTACTRebecca Grey Clinical Research Coordinator
cerebri.research@ubc.ca604-875-4111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026